Weronika Buczek

Weronika Buczek

Auto-generated profile, based on publicly available information

Weronika Buczek

Pope John Paul II Independent Public Regional Hospital in Zamość , ul. Aleje Jana Pawła II 10, 22-400 Zamość, Poland

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2022 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
WBWeronika Buczek
Weronika Buczek
MWMikołaj Wiśniewski
Mikołaj Wiśniewski
RORafał Oleszczuk
Rafał Oleszczuk
IKIga Kozińska
Iga Kozińska
MOMaciej Orczykowski
Maciej Orczykowski
Introduction and methods Artificial Intelligence(AI) is a relatively new branch of science that studies the display of intelligent behavior by machines and its use in advanced analysis and computation. Due to the potential use of AI, it has also been introduced into medicine and nephrology. The following article is an analysis of the current knowledge on the potential of AI in nephrology and its relevance to clinicians based on the latest publications contained in the PubMed and Google Scholar databases. Stage of knowledge AI found its application in the prognosis of the development of IgA nephropathy thanks to the use of a neural network, which by analyzing the results of research and the drugs used in a large group of patients has learned to detect patients at high risk of developing severe complications at the beginning of the disease. What is more, AI makes it possible to detect DKD earlier and delay renal replacement therapy. In patients undergoing hemodialysis, artificial intelligence developed a model that calculated the appropriate duration of the procedure and adjusted drugs to control blood pressure. Another example of the use of AI is its use in relation to patients undergoing kidney transplantation. The AI calculates the beneficial concentration of an immunosuppressive drug specifically for a given patient, which allows clinicians to limit adverse effects. Summary AI is a breakthrough technology that is constantly being developed. Despite the high cost of implementing this technology, it is believed that it could represent the future of medicine and be a new way in treatment techniques and in the early detection of diseases in nephrology.

3 March 2025 in Journal of Pre-Clinical and Clinical Research
Verified
Journal Article
Open access
KBKarolina Barzyk
Karolina Barzyk
WBWeronika Buczek
Weronika Buczek
MKMarcelina Kurek
Marcelina Kurek
MCMagdalena Chroscinska-Krawczyk
Magdalena Chroscinska-Krawczyk
Introduction and objective: Tourette syndrome is a neuropsychiatric disorder that begins in childhood and reaches its peak just before adolescence. The disorder is severely troublesome for patients not only by the motor and phonic tics that occur, but also by the often co-occurring behavioural...

15 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
KBKarolina Barzyk
Karolina Barzyk
MPMagdalena Pietrzak
Magdalena Pietrzak
JWJolanta Wiśniewska
Jolanta Wiśniewska
WBWeronika Buczek
Weronika Buczek
MWMikołaj Wiśniewski
Mikołaj Wiśniewski
EPEmil Pencuła
Emil Pencuła
Background: Ulcerative colitis (UC) is a chronic condition marked by widespread inflammation of the mucosa of the colon and rectum. In view of the growing prevalence and hardships during the disease process, it is necessary to search for new therapeutical approaches. Research objectives: The aim of this review is to investigate the new diet named Ulcerative Colitis Exclusion Diet (UCED), which may help in maintaining a stable course of UC. Methods: The review was conducted using the PubMed database mainly from 2018 to 2024 with the use of keywords: “ulcerative colitis”, “ulcerative colitis treatment”, “ulcerative colitis diet”, “gastrointestinal microbiome”. Some of the data comes from the clinical trials website ”https://clinicaltrials.gov”. Key findings: UC is a chronic, immune-mediated inflammatory condition of the colon, belonging to inflammatory bowel diseases (IBD). The exact pathogenesis is unknown, yet many factors contribute to the onset and exacerbation of the disease. Currently, the prevalence is increasing worldwide. The most common symptoms are diarrhea and lower gastrointestinal bleeding combined with other, less specific manifestations. Making a diagnosis requires endoscopic evaluation of the colon. Pharmacological treatment is insufficient in some cases, and therefore, new therapeutic approaches are being explored. Intake of strictly defined products and avoidance of certain substances according to UCED guidelines may result in beneficial gut microbiota changes and reduction of inflammation, leading to a better disease control. Conclusions: Considering the challenges of UC and the importance of proper nutrition in IBD, the introduction of a proper diet is desirable. Although UCED is a relatively innovative dietary approach, it appears promising and requires further research.

8 May 2026 in Medical Science Pulse
Verified
Journal Article
Closed access
MWMikołaj Wiśniewski
Mikołaj Wiśniewski
WBWeronika Buczek
Weronika Buczek
JWJolanta Wiśniewska
Jolanta Wiśniewska
PBPiotr Bartnik
Piotr Bartnik
KBKarolina Barzyk
Karolina Barzyk
MPMagdalena Pietrzak
Magdalena Pietrzak
Background: Creatine plays a key role in cellular energy metabolism via the phosphocreatine–creine kinase system, enabling rapid ATP regeneration to support brain function. Evidence suggests that creatine supplementation may enhance cognition, improve brain bioenergetics, and provide neuroprotection in conditions associated with energy deficits, including sleep deprivation, hypoxia, depression, neurodegenerative diseases, and traumatic brain injury. However, findings remain inconsistent, and the optimal strategies for increasing brain creatine levels are still unclear.Aim of the study: To summarize the current evidence on the effects of creatine supplementation on brain creatine levels, cognitive function, and neuroprotection, particularly in stress-related and neurological conditions.Materials and methods: A narrative review of human and animal studies was conducted, including NMR spectroscopy research on brain creatine, randomized trials investigating cognition, and studies on depression, neurodegeneration, and brain injury. Research on guanidinoacetic acid (GAA) supplementation was also included.Results: Creatine supplementation increased brain creatine levels by 3–10% in most studies, with effects varying according to dose, duration, and brain region. GAA demonstrated greater efficacy, increasing brain creatine levels by up to 16%. Cognitive outcomes were mixed but generally showed improvement under conditions of high energy demand (e.g., sleep deprivation and hypoxia). Benefits were observed in memory performance among older adults and individuals with low baseline creatine levels. Preliminary evidence also suggests potential benefits in depression (especially in combination with SSRIs), neuroprotection following traumatic brain injury, and possible therapeutic effects in Alzheimer’s disease, although human data remain limited.Conclusions: Creatine is a safe and accessible supplement with the potential to support brain metabolism, enhance cognition under stress, and provide neuroprotection. GAA may be more effective than creatine in increasing brain creatine levels. Further clinical trials are needed to confirm its efficacy and optimize supplementation strategies.

6 January 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MPMagdalena Pietrzak
Magdalena Pietrzak
MWMikołaj Wiśniewski
Mikołaj Wiśniewski
KBKarolina Barzyk
Karolina Barzyk
ABAgata Brzyska
Agata Brzyska
WBWeronika Buczek
Weronika Buczek
UMUrszula Marzec
Urszula Marzec
Introduction: Radiation-induced skin injury is a frequent adverse effect of radiotherapy, ranging from early erythema and desquamation to chronic fibrosis, pigment alteration, and telangiectasia. These reactions can reduce patient comfort, impair daily activities, and occasionally limit delivery of optimal cancer therapy. This review outlines current knowledge on mechanisms, prevention, and management of radiation-induced skin injury, including pharmacological, physical, and supportive strategies. Methodology: A targeted literature search was performed in a medical research database using terms related to radiation, radiotherapy, and management of skin reactions. Recent clinical trials, observational studies, and systematic reviews meeting inclusion criteria were analyzed to identify prevailing preventive and therapeutic approaches. Results: Skin injury results from DNA damage, inflammatory signaling, and oxidative stress affecting normal skin cells. Acute reactions typically occur within three months of exposure, whereas chronic changes may persist for years. Key risk factors include high radiation dose, sensitive anatomical sites such as thin or folded skin, and concurrent systemic cancer therapies. Evidence supports preventive measures including gentle cleansing, routine moisturization, topical corticosteroids, protective barrier films, and optimized radiation planning. Adjunctive treatments such as hyperbaric oxygen therapy, silver-based dressings, botanical products, and vitamin-based agents show potential benefit, although current evidence is limited by small sample sizes and methodological variability. Conclusion: Radiation-induced skin injury remains a clinical problem. Multimodal management combining standardized skin care, targeted pharmacologic treatments, and supportive interventions may reduce severity and improve patient outcomes. Further studies are required to define evidence-based management guidelines.

20 December 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PBPiotr Bartnik
Piotr Bartnik
MWMikołaj Wiśniewski
Mikołaj Wiśniewski
WBWeronika Buczek
Weronika Buczek
JWJolanta Wiśniewska
Jolanta Wiśniewska
MPMagdalena Pietrzak
Magdalena Pietrzak
UMUrszula Marzec
Urszula Marzec
Background: Blood donation, traditionally regarded as a „priceless gift of life” and altruistic act of supporting healthcare systems, has increasingly been examined as a potential health - modifying intervention for donors themselves. This review synthesizes current evidence on the physiological benefits, potential risks and adaptive responses associated with regular blood donation. Health benefits of blood donation include reductions in body iron stores, which can transform into decreased oxidative stress, improved metabolic profiles and lower long - term cardiovascular risk in selected populations. Clinical trials suggests potential modulations in inflammatory markers and improved vascular function following regular donation. However, blood donation is not procedure without risk. There are some acute side effects such as for example vasovagal reactions, temporary weakness and reduced exercise tolerance, while long - term concerns include iron - deficiency anemia, impaired physical performance in high - demand athletes and possible cumulative effects of frequent phlebotomy. Physiological adaptations to recurrent blood loss are for example enhanced erythropoiesis, plasma volume expansion, and changes in iron - regulatory pathways which play a central role in shaping donors’ responses and may differ according to sex, age, nutritional status and donation frequency. By integrating data from clinical trials, epidemiological studies and research this review highlights the complex interplay between the therapeutic potential and physiological cost of blood donation. Understanding these dynamics is crucial for optimizing donor safety, refining eligibility and recovery guidelines and exploring whether periodic blood removal could serve as a targeted intervention in specific clinical or metabolic contexts. Aim: The aim of this study is to investigate the physiological, metabolic and cardiovascular effects of regular blood donation, in particular donor safety, risk factors and potential health benefits associated with regular blood donation. Methods: A review of scientific articles published on ResearchGate and PubMed from 1998 to 2025. Results: Regular blood donation leads to many physiological adaptations, including reduced iron stores, improved lipid profiles, decreased oxidative stress and lower inflammation. Cardiovascular benefits such as for example reduced risk of myocardial infarction have been reported too. Common side effects include vasovagal reactions, temporary hypotension, and, rarely, iron - deficiency anemia in frequent donors. Overall, blood donation can provide health benefits when monitored appropriately. Conclusion: Blood donation is not only a altruistic act but also a physiological and metabolic intervention. Regular donations are associated with improved cardiovascular and metabolic benefits, reduced oxidative stress and enhanced iron regulation, while side effects remain generally smooth and manageable. With adequate donor screening and monitoring, blood donation can provide significant health benefits, supporting both individual well - being and societal needs for blood supply.